Physician
Boston Children's Health Physicians, LLP
Boston Children's Health Physicians, LLP was paid $52.95M by Medicaid between Jan 2018 and Dec 2024, across 194 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoBOSTON CHILDREN'S HEALTH PHYSICIANS, LLP
HAWTHORNE, NY 10532
HAWTHORNE, NY 10532
33aNPI1467454967assigned 08/15/2005
33bProvider typeChild & Adolescent Psychiatry Physician
28Total paid$52.95M
24GClaims973,915
24DCodes billed194
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Child & Adolescent Psychiatry Physician providers in New York
Rank by total paid#1 of 77
Median peer was paid$13K
This provider vs. median4,044×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 97,874 | $5.63M | |
| 2019 | 82,811 | $4.24M | |
| 2020 | 100,348 | $4.93M | |
| 2021 | 166,814 | $7.17M | |
| 2022 | 211,877 | $10.20M | |
| 2023 | 187,972 | $11.90M | |
| 2024incomplete | 126,219 | $8.89M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 127,047 | 111,637 | $14.59M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 22% | 58,156 | 52,175 | $11.50M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 79,274 | 71,985 | $6.51M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.2% | 69,811 | 67,134 | $1.69M |
| 99205 | Prolong outpt/office vis | 2.5% | 4,870 | 4,761 | $1.32M |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 2.4% | 2,612 | 605 | $1.26M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.1% | 10,608 | 10,407 | $1.11M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.9% | 7,346 | 2,394 | $1.03M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 8,437 | 8,294 | $882K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.6% | 4,114 | 4,014 | $826K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.5% | 7,170 | 6,959 | $816K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 18,205 | 16,646 | $806K |
182 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 7,038 | $657K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.2% | 2,163 | $622K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.1% | 2,879 | $600K |
| 96112 | <1% | 3,183 | $479K | |
| 99460 | <1% | 4,281 | $471K | |
| 99468 | <1% | 404 | $456K | |
| 94010 | <1% | 10,658 | $405K | |
| 95812 | <1% | 995 | $390K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,588 | $331K |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 561 | $293K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 3,181 | $286K |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 1,865 | $277K |
| 99223 | Prolong inpt eval add15 m | <1% | 1,109 | $257K |
| 99051 | <1% | 12,306 | $246K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 973 | $231K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,568 | $215K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 16,552 | $210K |
| 99441 | <1% | 3,721 | $199K | |
| 96160 | <1% | 35,728 | $185K | |
| 92587 | <1% | 7,595 | $182K | |
| 95720 | <1% | 783 | $178K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,322 | $177K |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 1,134 | $177K |
| 95708 | <1% | 562 | $171K | |
| 93320 | <1% | 3,312 | $159K | |
| 93000 | <1% | 9,064 | $152K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,126 | $138K |
| 99462 | <1% | 2,780 | $136K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,011 | $120K |
| 96127 | <1% | 19,135 | $117K | |
| 93325 | <1% | 4,830 | $106K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 601 | $102K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15,689 | $100K |
| 95700 | <1% | 496 | $99K | |
| 99464 | <1% | 1,000 | $85K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 584 | $71K |
| 99442 | <1% | 751 | $68K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 463 | $66K |
| 87631 | <1% | 796 | $66K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 386 | $63K |
| 96111 | <1% | 535 | $58K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,553 | $52K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 952 | $51K |
| 90837 | Psychotherapy session, about an hour | <1% | 486 | $50K |
| 92551 | <1% | 10,965 | $45K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,449 | $42K |
| 99173 | <1% | 14,585 | $36K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,052 | $34K |
| 87428 | <1% | 747 | $33K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 586 | $33K |
| 92558 | <1% | 3,732 | $32K | |
| 86580 | <1% | 3,037 | $32K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 591 | $32K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 195 | $31K |
| 99245 | <1% | 570 | $30K | |
| 90461 | <1% | 6,970 | $30K | |
| 92060 | <1% | 355 | $28K | |
| 99354 | <1% | 177 | $25K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 644 | $25K |
| 85018 | <1% | 13,097 | $25K | |
| 92552 | <1% | 1,917 | $24K | |
| 95951 | <1% | 63 | $24K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,942 | $22K |
| 99177 | <1% | 4,460 | $21K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,978 | $21K |
| 97803 | <1% | 227 | $20K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 178 | $20K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 187 | $18K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 98 | $17K |
| 95117 | <1% | 1,152 | $17K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 188 | $17K |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 300 | $17K |
| G0008 | Administration of influenza virus vaccine | <1% | 883 | $16K |
| 99401 | <1% | 393 | $14K | |
| 0071A | <1% | 347 | $14K | |
| 87081 | <1% | 3,722 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 974 | $13K |
| 0072A | <1% | 312 | $12K | |
| 95719 | <1% | 54 | $10K | |
| 94664 | <1% | 564 | $10K | |
| 83655 | <1% | 806 | $10K | |
| 81002 | <1% | 4,856 | $10K | |
| 95012 | <1% | 331 | $8K | |
| 99356 | <1% | 70 | $8K | |
| 87807 | <1% | 768 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 811 | $8K |
| 4124F | <1% | 444 | $8K | |
| 81000 | <1% | 2,076 | $8K | |
| 93040 | <1% | 1,834 | $7K | |
| 97802 | <1% | 201 | $7K | |
| 90620 | <1% | 431 | $6K | |
| 87634 | <1% | 202 | $6K | |
| 81003 | <1% | 3,691 | $6K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 37 | $5K |
| 0001A | <1% | 131 | $5K | |
| 99219 | <1% | 28 | $5K | |
| 90686 | <1% | 16,418 | $5K | |
| 93304 | <1% | 30 | $4K | |
| 36416 | <1% | 14,496 | $4K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 64 | $4K |
| 90715 | <1% | 756 | $4K | |
| 90651 | <1% | 1,072 | $4K | |
| 99443 | <1% | 24 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 202 | $3K |
| 92015 | Determination of refractive state | <1% | 313 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 71 | $3K |
| 96161 | <1% | 937 | $3K | |
| 99381 | <1% | 25 | $3K | |
| 94060 | <1% | 99 | $3K | |
| 82947 | <1% | 776 | $3K | |
| 99220 | <1% | 13 | $3K | |
| 99495 | <1% | 13 | $2K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 154 | $2K |
| 94760 | <1% | 28,513 | $2K | |
| 87420 | <1% | 198 | $2K | |
| 0002A | <1% | 43 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 155 | $2K |
| 76825 | <1% | 12 | $1K | |
| 94726 | <1% | 69 | $1K | |
| 82465 | <1% | 310 | $1K | |
| 99417 | Prolong home eval add 15m | <1% | 28 | $1K |
| 94729 | <1% | 69 | $1K | |
| 99174 | <1% | 115 | $1K | |
| 92553 | <1% | 87 | $1K | |
| A4206 | Syringe with needle, sterile, 1 cc or less, each | <1% | 13,142 | $1K |
| 83718 | <1% | 216 | $1K | |
| 93227 | <1% | 46 | $1K | |
| 95816 | <1% | 13 | $974.38 | |
| 99072 | <1% | 164,223 | $888.33 | |
| 99188 | <1% | 51 | $844.50 | |
| 90480 | <1% | 24 | $840.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 47 | $816.62 |
| 95125 | <1% | 33 | $799.51 | |
| 87070 | <1% | 98 | $770.34 | |
| 99429 | <1% | 27 | $675.00 | |
| 90785 | <1% | 47 | $577.41 | |
| 36406 | <1% | 42 | $565.98 | |
| 95251 | <1% | 12 | $543.86 | |
| 0053A | <1% | 13 | $520.00 | |
| 82272 | <1% | 153 | $502.79 | |
| 93321 | <1% | 13 | $423.38 | |
| 87999 | <1% | 214 | $325.00 | |
| 90619 | <1% | 751 | $321.76 | |
| 90656 | <1% | 1,195 | $293.62 | |
| 90677 | <1% | 577 | $266.70 | |
| 90670 | <1% | 1,938 | $251.03 | |
| 92567 | <1% | 12 | $231.50 | |
| 90716 | <1% | 484 | $177.68 | |
| 90734 | <1% | 477 | $144.41 | |
| 80061 | Lipid panel | <1% | 14 | $135.42 |
| 90661 | <1% | 117 | $112.81 | |
| 90707 | <1% | 540 | $93.96 | |
| 99050 | <1% | 12 | $79.80 | |
| 99000 | <1% | 10,561 | $63.95 | |
| 98960 | <1% | 173 | $54.95 | |
| 90744 | <1% | 722 | $27.53 | |
| 90713 | <1% | 154 | $25.00 | |
| 90700 | <1% | 627 | $25.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 75 | $21.55 |
| 36000 | <1% | 34 | $20.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 16 | $3.92 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 24 | $2.14 |
| A4215 | Needle, sterile, any size, each | <1% | 57 | $0.70 |
| 91307 | <1% | 833 | $0.08 | |
| 90672 | 0% | 13 | $0.00 | |
| 90710 | 0% | 348 | $0.00 | |
| 99367 | 0% | 72 | $0.00 | |
| 90633 | 0% | 1,199 | $0.00 | |
| 91300 | 0% | 268 | $0.00 | |
| 90648 | 0% | 280 | $0.00 | |
| 90685 | 0% | 43 | $0.00 | |
| 90658 | 0% | 27 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 18 | $0.00 |
| 90698 | 0% | 1,283 | $0.00 | |
| 90680 | 0% | 1,151 | $0.00 | |
| 90696 | 0% | 394 | $0.00 | |
| 90697 | 0% | 37 | $0.00 | |
| 90674 | 0% | 27 | $0.00 | |
| 91305 | 0% | 40 | $0.00 | |
| 90660 | 0% | 20 | $0.00 | |
| 36591 | 0% | 55 | $0.00 | |
| 90647 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHAW, ROBERT (CHIEF OPERATING OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Carroll Arthritis, PA | Westminster, MD | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.